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For this study the CI of the CTV-breast needed to be >0.8. 
Furthermore, we used the same method as Struikmans et al. 
to compare the derived CIs for all RTTs with those of the 
delineation of the 2 radiation oncologists [1]. 
Results: The mean CI for each single patient was higher than 
0.8 for the RTTs and radiation oncologists together. In both 
separate groups the mean CI was higher than 0.8 as well, the 
values are indicated in table 1. 
Conformity Index  
   
 
RT oncologists + 
RTTs 
RTTs 
RT 
oncologists 
Patient 1 
Patient 2 
Patient 3 
Patient 4 
Patient 5 
0.901 
0.904 
0.875 
0.912 
0.920 
0.901 
0.911 
0.872 
0.911 
0.918 
0.898 
0.867 
0.876 
0.926 
0.923 
Average of the pts 0.902 0.903 0.898 
Standard 
deviation 
0.017 0.018 0.027 
Table 1. Conformity Indices 
 
The results show that the CI of the CTV-breast for the RTTs 
and radiation oncologists do not differ significantly. In 
addition we noted that the visual differences are mainly 
located on the lateral, medial and dorsal side of the breast. 
This is shown in the figure below.  
 
 
Figure 1. patient no.2 and no.3, delineations of RTTs and 
radiation oncologists 
 
Conclusion : With a mean CI of about 0.9 for both groups, 
the CIs were >0.8 for the five delineated patients.  
Recommendations: We recommend that RTTs will delineate 
the CTV-breast in our radiotherapy department. When the 
RTTs delineated the CTV-breast, this will be supervised by 
the radiation oncologists. Both the RTTs and the radiation 
oncologists need to work according to the delineation 
guidelines. The final approval must be done by the radiation 
oncologist. 
Based on the average number of 100 patients treated with 
breast conserving radiotherapy per year we recommend that 
five RTTs need to be trained to delineate the CTV-breast in 
breast conserving radiotherapy. In our opinion it is enough 
when the five RTTs delineate at least twenty patients a year.  
[1] H Struikmans et al., Radiother Oncol. 2005 
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Purpose/Objective: Contouring organs at risk is generally 
performed by the RTTs. These organs in the lower pelvis have 
large variations, especially in patients undergone surgical 
treatment. The objective of the study is to analyze the 
contouring process of organs at risk in lower pelvis in patients 
undergoing postoperative radiotherapy, to present the most 
frequently observed problems and to point out the solutions 
to overcome them. 
Materials and Methods: Postoperative treatment was applied 
to 157 patients in 'Tokuda Hospital Sofia' in the period 
XI.2009 – XI.2014. From the total number 28 patients were 
operated due to prostate carcinoma and 129 patients due to 
carcinoma uteri. Patients were scanned on a CT 
LifgtSpeedTMRT16 with the protocol for Pelvis scanning without 
intravenous contrast. The patients were prepared for CT 
scanning and irradiation with empty bladder. The protocol 
Helical full, 1,0 sec rotation speed, pitch 0.938:, 
thickness/interval 0.5 mm; Large FOV; Auto mA. A planning 
system ERGO++ was used to contour organs at risk. Obtained 
data were CT processed using Microsoft ExcelTM. 
Results: It was found in 10% of male patients have expressed 
atony of the bladder and 30% showed severe incontinence. 
Within the female patients 30% showed atonia and only 10% 
have incontinence, but at considerably lower level. Within 
prostate cancer patients there were no cases showing 
lymphocele. Among the patients operated from carcinoma 
uteri 20% were found with significant degree of lymphocele, 
as in 5% of them additional surgical treatment was applied. In 
one patient bilateral aneurism of the common iliac arteries 
was found. 
Conclusions: The knowledge of the normal anatomy of lower 
pelvis and the capabilities for contouring organs at risk has 
been incorporated into the modern planning algorithms and 
allows reduction the dose in the organs at risk. There are 
often considerable aberrations in the anatomic localization, 
shape and size of the organs at risk in the patients undergone 
surgery. This requires high level of knowledge of those 
variations, individual approach and very often directing the 
patient for additional surgical treatment. Such requirements 
raise creativity in the skills of RTTs at a new higher level. 
Thus, the team working capabilities of RTTs together with 
the physicians are improved and patients are provided with 
best choice of treatment. 
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Purpose/Objective: Institute Verbeeten is located in 3 cities, 
Tilburg, Breda, and 's-Hertogenbosch. Only in Tilburg we have 
access to a planning-CT scan. As patients have to travel for 
the CT scan a method has been developed to use the CBCT as 
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imaging device for treatment planning. This method will be 
used for palliative patients with painful vertebral metastases. 
Our challenge is to determine the impaired vertebrae on the 
CBCT. These vertebrae are known in advance from the 
diagnostic scan. The CBCT only covers 16 cm, which makes it 
impossible to count the vertebrae for cases in which either L5 
or C1 is not shown.  
Materials and Methods: A Varian iX accelerator with OBI is 
used to make the CBCT. Treatment planning is performed 
with EclipseTM v10.0 (Varian). We use a homemade bottom 
plate on the table which contains lead BB's every 10cm. 
These marker positions are distinguishable by the number of 
BB's. We take a kV-image including either C1 or L5 and note 
at which vertebra the first marker position is projected. 
Then, we shift the table, take another image with both the 
first and a second marker position, and note at which 
vertebra this second marker position is projected. We repeat 
this procedure until the impaired vertebrae and the marker 
closest to these vertebrae is imaged. We perform the CBCT 
with the center at these impaired vertebrae. The CBCT is 
used for treatment planning. QA of the calculation shows that 
the dose calculation on the CBCT scan corresponds with the 
calculation on the CT scan with deviations up to 1.5% for a 
6MV beam, calculated with the AAA algorithm. The patient is 
treated the same day without a regular planning-CT. 
Results: We have tested the imaging procedure on an 
anthropomorphous phantom. Figure 1 shows the kV-images 
when counting starts at L5. The red arrow and the blue arrow 
each denote the same patient position on the couch. In 
between the images the couch has been shifted 
approximately 10 cm.  
 
Fig 1 
 
Conclusions: We intend to perform the treatment of 
vertebral metastases for palliative patients close to their 
home in a one-stop procedure. We use an imaging procedure 
based on kV-imaging with the aid of a homemade bottom 
plate, followed by a CBCT. The CBCT is used for treatment 
planning. The procedure has been tested on an 
anthropomorphous phantom and will be used clinically from 
January 2015.  
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Purpose/Objective: Our goal was to optimize the bladder 
volume on the planning CT scan according to the department 
bladder filling protocol, for patients referred for pelvic 
radiotherapy. 
Our hypothesis was, the ultrasound bladder scanner could 
define the bladder volume, with the accuracy 100ml, 
compared to the planning CT scan. We also wanted to 
evaluate the bladder volume changes according to time. 
Materials and Methods: All patients were instructed to 
comply with a bladder filling protocol before planning CT 
scan. Optimal filling was considered to be 150-300 ml. 
A radiographer measured the bladder volumes three times, 
according to the list below.  
1. ultrasound bladder scan before patient set up, average of 
3 measurements 
2. measurement on planning CT scan, using bladder outline 
contours  
3. ultrasound bladder scan after planning CT scan, average of 
3 measurements 
All scans were time registered. If the bladder volume in scan 
1 was >300 ml we asked the patients to empty the excess 
bladder volume corresponding to measurements in cups. 
Afterwards we restarted the measuring. These reported 
volumes are all after emptying. If the bladder volume in scan 
1 was 150-300 ml or < 150 ml, we did not interfere. 
Results: We collected data from 33 patients, with the 
following cancer diagnoses: Anal, prostate, Rectal and 
gynecological. All patients had scan 1 and scan 2 and 30 
patients also had scan 3. All patients who were asked to 
empty excess bladder volume could cooperate to the 
instructions. 
The median time span between scan 1 and scan 2 was 12 min 
(range 6-45 minutes) and the median time span between scan 
1 and scan 3 was 17 min (range 10-45 min). The median 
bladder volume in scan1 was 103 ml (range 24-264 ml), in 
scan 2: 179 ml (range 61-400 ml) and in scan 3: 181ml (range 
16-312 ml) 
 
 
